Vimarsana
Biggest News Aggregation in the World

Page 5 - Brian Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Hoffmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Hoffmann Today - Breaking & Trending Today

The 'AI effect' headlines IBM Think 2021 as enterprises emerge from coronaconomy - Vimarsana News

The 'AI effect' headlines IBM Think 2021 as enterprises emerge from coronaconomy

SHARE The business world is changing. Has changed. The COVID-19 pandemic drove companies to transform three times faster in 2020 than in previous years, with 66% shifting to more cloud-based business activities. As enterprise clients undergo rapid change in a turbulent business environment, they need guidance. They may find it at the upcoming IBM Think 2021 virtual event, which promises to teach attendees how to “navigate change through transformation, automation and modernization.”     Business resiliency is the number one attribute required to thrive in the post-pandemic economy, ac...

Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg - Vimarsana News

Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg

Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg Important new option for reversing opioid overdoses News provided by Share this article Share this article LONDON, April 30, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of KLOXXADO TM (naloxone hydrochloride) nasal spray 8mg, by the US Food and Drug Administration (FDA) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric...

Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Director/PDMR Shareholding - Vimarsana News

Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Director/PDMR Shareholding

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Hikma intros generic Northera - Vimarsana News

Hikma intros generic Northera

Droxidopa capsules had a market value of approximately $353 million in the 12 months ended November 2020, according to IQVIA.

Is Diet Soda Killing Us? Here's What to Know About Aspartame - Vimarsana News

Is Diet Soda Killing Us? Here's What to Know About Aspartame

For years I only sipped on brown drinks: Morning was a Starbucks Vente Redeye and then around noon that gave way to Diet Coke number one, then two, and three, and possibly more, sometimes five or more in a day. My art director and friend told me "that stuff is poison." It turns out she was right. The first time I gave it up, it was on a ski holiday and I managed to get off the stuff for about six months, thinking it would help me lose my cellulite (I figured there might be a connection between fat cells and sodium or chemicals in my usual diet sodas). It didn't. I jumped back on the Diet...

Source: wkdq.com